Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(16.28%)
USD 0.01
(16.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.76 Million USD | -16.1% |
| 2022 | 2.09 Million USD | 175.82% |
| 2021 | 761 Thousand USD | -5.7% |
| 2020 | 807 Thousand USD | 33.83% |
| 2019 | 603 Thousand USD | 7.3% |
| 2018 | 562 Thousand USD | -32.61% |
| 2017 | 834 Thousand USD | -18.63% |
| 2016 | 1.02 Million USD | 1.79% |
| 2015 | 1 Million USD | -21.57% |
| 2014 | 1.28 Million USD | 14.75% |
| 2013 | 1.11 Million USD | 23.37% |
| 2012 | 907 Thousand USD | 1.68% |
| 2011 | 892 Thousand USD | -21.75% |
| 2010 | 1.14 Million USD | 6.34% |
| 2009 | 1.07 Million USD | 13.8% |
| 2008 | 942 Thousand USD | -25.24% |
| 2007 | 1.26 Million USD | -59.67% |
| 2006 | 3.12 Million USD | 92.36% |
| 2005 | 1.62 Million USD | 27.47% |
| 2004 | 1.27 Million USD | -28.83% |
| 2003 | 1.79 Million USD | 13.01% |
| 2002 | 1.58 Million USD | -47.24% |
| 2001 | 3 Million USD | 6.38% |
| 2000 | 2.82 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 141 Thousand USD | -33.49% |
| 2023 Q2 | 748 Thousand USD | 141.29% |
| 2023 Q1 | 310 Thousand USD | -33.19% |
| 2023 FY | 1.76 Million USD | -16.1% |
| 2023 Q4 | 212 Thousand USD | -56.73% |
| 2023 Q3 | 490 Thousand USD | -34.49% |
| 2022 Q2 | 605 Thousand USD | 3.6% |
| 2022 FY | 2.09 Million USD | 175.82% |
| 2022 Q3 | 446 Thousand USD | -26.28% |
| 2022 Q1 | 584 Thousand USD | 229.94% |
| 2022 Q4 | 464 Thousand USD | 4.04% |
| 2021 Q4 | 177 Thousand USD | -8.76% |
| 2021 Q1 | 101 Thousand USD | 0.0% |
| 2021 Q2 | 289 Thousand USD | 186.14% |
| 2021 FY | 761 Thousand USD | -5.7% |
| 2021 Q3 | 194 Thousand USD | -32.87% |
| 2020 FY | 807 Thousand USD | 33.83% |
| 2019 FY | 603 Thousand USD | 7.3% |
| 2018 Q2 | 151 Thousand USD | -7.93% |
| 2018 FY | 562 Thousand USD | -32.61% |
| 2018 Q1 | 164 Thousand USD | 0.0% |
| 2017 Q3 | 208 Thousand USD | -11.86% |
| 2017 FY | 834 Thousand USD | -18.63% |
| 2017 Q2 | 236 Thousand USD | 3.51% |
| 2017 Q1 | 228 Thousand USD | -0.44% |
| 2016 Q3 | 251 Thousand USD | -9.71% |
| 2016 Q1 | 267 Thousand USD | 4.71% |
| 2016 Q4 | 229 Thousand USD | -8.76% |
| 2016 Q2 | 278 Thousand USD | 4.12% |
| 2016 FY | 1.02 Million USD | 1.79% |
| 2015 Q4 | 255 Thousand USD | -2.3% |
| 2015 Q3 | 261 Thousand USD | 5.67% |
| 2015 FY | 1 Million USD | -21.57% |
| 2015 Q2 | 247 Thousand USD | 1.23% |
| 2015 Q1 | 244 Thousand USD | -45.05% |
| 2014 FY | 1.28 Million USD | 14.75% |
| 2014 Q2 | 278 Thousand USD | -5.44% |
| 2014 Q1 | 294 Thousand USD | 1.38% |
| 2014 Q4 | 444 Thousand USD | 65.67% |
| 2014 Q3 | 268 Thousand USD | -3.6% |
| 2013 Q1 | 250 Thousand USD | 23.76% |
| 2013 Q2 | 274 Thousand USD | 9.6% |
| 2013 FY | 1.11 Million USD | 23.37% |
| 2013 Q4 | 290 Thousand USD | -4.92% |
| 2013 Q3 | 305 Thousand USD | 11.31% |
| 2012 Q2 | 226 Thousand USD | -0.44% |
| 2012 Q1 | 227 Thousand USD | 8.1% |
| 2012 FY | 907 Thousand USD | 1.68% |
| 2012 Q4 | 202 Thousand USD | -19.84% |
| 2012 Q3 | 252 Thousand USD | 11.5% |
| 2011 Q3 | 220 Thousand USD | -5.58% |
| 2011 Q2 | 233 Thousand USD | 1.75% |
| 2011 Q1 | 229 Thousand USD | -51.69% |
| 2011 FY | 892 Thousand USD | -21.75% |
| 2011 Q4 | 210 Thousand USD | -4.55% |
| 2010 Q2 | 213 Thousand USD | -9.36% |
| 2010 Q4 | 474 Thousand USD | 118.43% |
| 2010 Q3 | 217 Thousand USD | 1.88% |
| 2010 Q1 | 235 Thousand USD | 0.43% |
| 2010 FY | 1.14 Million USD | 6.34% |
| 2009 Q3 | 288 Thousand USD | 4.35% |
| 2009 FY | 1.07 Million USD | 13.8% |
| 2009 Q2 | 276 Thousand USD | 0.73% |
| 2009 Q4 | 234 Thousand USD | -18.75% |
| 2009 Q1 | 274 Thousand USD | -6.48% |
| 2008 FY | 942 Thousand USD | -25.24% |
| 2008 Q3 | 180 Thousand USD | -22.75% |
| 2008 Q2 | 233 Thousand USD | -0.43% |
| 2008 Q1 | 234 Thousand USD | -40.61% |
| 2008 Q4 | 293 Thousand USD | 62.78% |
| 2007 FY | 1.26 Million USD | -59.67% |
| 2007 Q4 | 394 Thousand USD | 34.93% |
| 2007 Q3 | 292 Thousand USD | 24.79% |
| 2007 Q2 | 234 Thousand USD | -31.18% |
| 2007 Q1 | 340 Thousand USD | -76.29% |
| 2006 Q1 | 448 Thousand USD | -34.5% |
| 2006 FY | 3.12 Million USD | 92.36% |
| 2006 Q4 | 1.43 Million USD | 147.67% |
| 2006 Q3 | 579 Thousand USD | -12.8% |
| 2006 Q2 | 664 Thousand USD | 48.21% |
| 2005 Q3 | 284 Thousand USD | -17.44% |
| 2005 Q4 | 684 Thousand USD | 140.85% |
| 2005 Q2 | 344 Thousand USD | 10.26% |
| 2005 Q1 | 312 Thousand USD | -35.4% |
| 2005 FY | 1.62 Million USD | 27.47% |
| 2004 FY | 1.27 Million USD | -28.83% |
| 2004 Q2 | 240 Thousand USD | -7.34% |
| 2004 Q3 | 292 Thousand USD | 21.67% |
| 2004 Q4 | 483 Thousand USD | 65.41% |
| 2004 Q1 | 259 Thousand USD | -46.38% |
| 2003 Q2 | 811 Thousand USD | 161.61% |
| 2003 Q1 | 310 Thousand USD | -4.02% |
| 2003 Q3 | 186 Thousand USD | -77.07% |
| 2003 FY | 1.79 Million USD | 13.01% |
| 2003 Q4 | 483 Thousand USD | 159.68% |
| 2002 Q3 | 312 Thousand USD | -38.34% |
| 2002 Q1 | 425 Thousand USD | -30.1% |
| 2002 FY | 1.58 Million USD | -47.24% |
| 2002 Q4 | 323 Thousand USD | 3.53% |
| 2002 Q2 | 506 Thousand USD | 19.06% |
| 2001 Q3 | 708 Thousand USD | -33.02% |
| 2001 Q4 | 608 Thousand USD | -14.12% |
| 2001 FY | 3 Million USD | 6.38% |
| 2001 Q1 | 629 Thousand USD | 0.0% |
| 2001 Q2 | 1.05 Million USD | 68.04% |
| 2000 FY | 2.82 Million USD | 0.0% |
| 2000 Q1 | 642 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Achiko AG | 6.78 Million USD | 74.046% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.04 Million USD | 78.104% |
| Cannabis Sativa, Inc. | 862.24 Thousand USD | -104.235% |
| CompuMed, Inc. | 2.91 Million USD | 39.638% |
| CompuGroup Medical SE & Co. KGaA | 1 Billion USD | 99.825% |
| Cogstate Limited | 23.64 Million USD | 92.551% |
| CareView Communications, Inc. | 7.21 Million USD | 75.607% |
| Craneware plc | 141.35 Million USD | 98.754% |
| Caduceus Software Systems Corp. | 2.07 Million USD | 15.309% |
| Certive Solutions Inc. | 1.5 Million USD | -16.73% |
| Drug Free Solution, Inc. | 1.39 Million USD | -26.17% |
| DATATRAK International, Inc. | 3.26 Million USD | 46.123% |
| Strainsforpains, Inc. | 149.72 Thousand USD | -1076.172% |
| Healixa Inc. | 6.56 Million USD | 73.173% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 3.28 Million USD | 46.325% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 702.92 Thousand USD | -150.525% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 491.28 USD | -358351.392% |
| IQ-AI Limited | 1.13 Million USD | -55.662% |
| Cannabiz Mobile, Inc. | 750.00 USD | -234700.0% |
| Mednow Inc. | 2.78 Million USD | 36.732% |
| Galileo Life Sciences, Inc. | 270.72 Thousand USD | -550.48% |
| MediXall Group, Inc. | 59.26 Thousand USD | -2871.249% |
| Mitesco, Inc. | 2.58 Million USD | 31.92% |
| MobileSmith, Inc. | 8.63 Million USD | 79.615% |
| NantHealth, Inc. | 94.47 Million USD | 98.136% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 12.38 Million USD | 85.778% |
| Patient Access Solutions, Inc. | 9.19 Million USD | 80.845% |
| Pharma-Bio Serv, Inc. | 3.94 Million USD | 55.406% |
| PPJ Healthcare Enterprises, Inc. | 141.33 Thousand USD | -1145.949% |
| Medical Cannabis Payment Solutions, Inc. | 12.18 Thousand USD | -14353.381% |
| Renalytix Plc | 29.04 Million USD | 93.936% |
| Revium Recovery Inc. | 677 Thousand USD | -160.118% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 369.00 USD | -477135.772% |
| Vaso Corporation | 46.39 Million USD | 96.205% |
| Vynleads, Inc. | 200.15 Thousand USD | -779.814% |